Siblings Conference Papers/Meeting Abstract [7/13] Collection Statistics Item counts issued in 3 years:6(14.29%) Items With Fulltext:42(100.00%) Download counts of the item Download times greater than 0:42(100.00%) Download times greater than 100:42(100.00%) Total Bitstream Download Counts:18766(81.79%) Last Update: 2024-12-01 10:27 Top Upload Loading... Top Download Loading... Recent Submissions Lysosomal-targeted doxorubicin deli... How to deal with frenemy NRF2: Targ... Synthesis and structure–activity re... Pilot study: Nutritional and precli... A novel NRF2/ARE inhibitor gossypol... Discovery and development of a nove... Type-3 hyaluronan synthase attenuat... Two new chromones and a new coumari... Xanthine derivatives reveal an allo... c-MYC-directed NRF2 drives malignan...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-25 of 42. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page

Date	Title	Relation
2023-11	Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death	Pharmacological Research. 2023 Nov;197:Article number 106945.
2023-03-28	Synthesis and structure–activity relationship of salvinal derivatives as potent microtubule inhibitors	International Journal of Molecular Sciences. 2023 Mar 28;24(7):Article number 6386.
2023-02-28	How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy	Journal of Food and Drug Analysis. 2023 Feb 28;31(3):387-407.
2023-01	Two new chromones and a new coumarin from the fruit of Cnidium monnieri (L.) Cusson	Natural Product Research. 2023 Jan;37(1):47-55.
2022-02-05	Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design	European Journal of Medicinal Chemistry. 2022 Feb 5;229:Article number 114043.
2022-01-17	Pilot study: Nutritional and preclinical safety investigation of fermented hispidin-enriched sanghuangporus sanghuang mycelia: A promising functional food material to improve sleep	Frontiers in Nutrition. 2022 Jan 17;8:Article number 788965.
2021-12-14	A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells	Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
2021-10-29	Type-3 hyaluronan synthase attenuates tumor cells invasion in human mammary parenchymal tissues	Molecules. 2021 Oct 29;26(21):Article number 6548.
2021-08-12	Xanthine derivatives reveal an allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2)	Journal of Medicinal Chemistry. 2021 Aug 12;64(15):11288-11301.
2021-03-15	Tea polyphenol epigallocatechin-3-gallate inhibits cell proliferation in a patient-derived triple-negative breast cancer xenograft mouse model via inhibition of proline-dehydrogenase-induced effects	Journal of Food and Drug Analysis. 2021 Mar 15;29(1):113-127.
2021-03-11	c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation	Theranostics. 2021 Mar 11;11(11):5232-5247.
2020-08	Two new diprenylated flavanones from Derris laxiflora Benth	Natural Product Research. 2020 Aug;34(15):2101-2108.
2020-04-02	MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer	Journal of Biomedical Science. 2020 Apr 2;27:Article number 46.
2020-02-10	Unique sulfur-aromatic interactions contribute to the binding of potent imidazothiazole indoleamine 2,3-Dioxygenase inhibitors	Journal of Medicinal Chemistry. 2020 Feb 10;63(4):1642-1659.
2019-12-24	ERK activation modulates cancer stemness and motility of a novel mouse oral squamous cell carcinoma cell line	Cancers. 2019 Dec 24;12(1):Article number 61.
2019-12	Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia	Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150.
2019-08	Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3-induced mitophagy	Cancer Medicine. 2019 Aug;8(10):4821-4835.
2018-12	Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O(6)-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells	Biochemical Pharmacology. 2018 Dec;158:327-338.
2018-06-15	2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition [Erratum: Organic and Biomolecular Chemistry. 2016 Jan;14(2):716-723.]	Organic and biomolecular chemistry. 2018 Jun 15;16:4734.
2018-04	4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy	Bioorganic Chemistry. 2018 Apr;77:600-607.
2017-12	Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells	Free Radical Biology and Medicine. 2017 Dec;113:505-518.
2017-08	Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness	Cancer Research. 2017 Aug;77(16):4305-4316.
2017-07	Drug repurposing for chronic myeloid leukemia: In silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors	Journal of Biomolecular Structure and Dynamics. 2017 Jun;35(8):1833-1848.
2017-07	Design, synthesis, and evaluation of thiazolidine-2,4-dione derivatives as a novel class of glutaminase inhibitors	Journal of Medicinal Chemistry. 2017 Jul;60(13):5599-5612.
2016-12	Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation	Oncotarget. 2016 Dec;7(52):86239-86256.

Showing items 1-25 of 42. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page